(5‐[2‐Chloro‐4‐ (trifluoromethyl)phenoxy]‐N‐ (methylsulfonyl)‐2‐nitrobenzamide) (Fomesafen); N‐(2,6‐Dichloro‐3‐ methylphenyl)‐5‐ amino‐1,3,4‐triazole‐2‐sulfonamide; 2,4‐Dichloro‐5‐ sulfamoylbenzoic acid; N‐Ethyl‐o‐ toluenesulfonamide; N‐Ethyl‐p‐toluenesulfonamide; 7-(Hexadecylsulfonylamino) ‐1H‐indole; Methyl 5‐{[(4,6‐dimethoxy‐2‐pyrimidinyl)amino]‐ carbonylaminosulfonyl} ‐3‐chloro‐1‐methyl‐1H‐pyrazole‐4‐carboxylate (Halosulfuron methyl); and Mixtures of ortho‐ and para-toluenesulfonamides
Duties (Base, Section 301, AD/CVD) are levied on product value (FOB) per US CBP rules — they do not change with shipping. Shipping & CBP fees only affect MPF, HMF, and the final Total Landed Cost.
Includes Section 301 (China) + applicable AD/CVD duties. Shipping & CBP fees are estimates. Actual costs may vary.
No AD/CVD or Section 301 risks for China
Standard MFN duty rate (0%) applies.
Data Sources